Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.80)
# 1,717
Out of 5,116 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $469.49 | -26.73% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $19.61 | +172.82% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $29.43 | +35.92% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $42.39 | -29.23% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $7.69 | +10.53% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.57 | -25.82% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.40 | +44,525.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $1.19 | +38,555.46% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $9.00 | +466.67% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $35.91 | -55.44% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $7.08 | +535.59% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $469.49
Upside: -26.73%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $19.61
Upside: +172.82%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $29.43
Upside: +35.92%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $42.39
Upside: -29.23%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $7.69
Upside: +10.53%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.57
Upside: -25.82%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.40
Upside: +44,525.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $1.19
Upside: +38,555.46%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $9.00
Upside: +466.67%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $35.91
Upside: -55.44%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $7.08
Upside: +535.59%